Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Journal of Geriatric Oncology
|
November 13, 2025
Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study
Thomas Grellety, Carine Bellera, Coralie Cantarel, et al.
Plos One
|
December 16, 2014
Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study
Pierre Soubeyran, Carine Bellera, Jean Goyard, et al.
BMJ Open
|
June 4, 2021
Individualised physical activity programme in patients over 65 years with haematological malignancies (OCAPI): protocol for a single-arm feasibility trial
Baptiste Fournier, Emmanuelle Nicolas-Virelizier, Chiara Russo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 10, 2024
Short course radiotherapy versus radiochemotherapy for locally advanced rectal cancers in the elderly (UNICANCER PRODIGE 42/GERICO 12 study): Quality of life and comprehensive geriatric assessment
Eric François, Nicolas Magné, Rabia Boulahssass, et al.
Translational Oncology
|
November 18, 2021
Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program
Philippe A Cassier, Clémentine Peyramaure, Valery Attignon, et al.
Science Translational Medicine
|
January 24, 2024
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers
Aurélien Voissière, Carlos Gomez-Roca, Sylvie Chabaud, et al.
Breast (Edinburgh, Scotland)
|
October 8, 2021
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database
Mylène Annonay, Lisa Gauquelin, Romain Geiss, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2022
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade
Carlos Gomez-Roca, Philippe Cassier, Dmitriy Zamarin, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Journal of Geriatric Oncology
|
November 13, 2025
Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study
Thomas Grellety, Carine Bellera, Coralie Cantarel, et al.
Plos One
|
December 16, 2014
Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study
Pierre Soubeyran, Carine Bellera, Jean Goyard, et al.
BMJ Open
|
June 4, 2021
Individualised physical activity programme in patients over 65 years with haematological malignancies (OCAPI): protocol for a single-arm feasibility trial
Baptiste Fournier, Emmanuelle Nicolas-Virelizier, Chiara Russo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 10, 2024
Short course radiotherapy versus radiochemotherapy for locally advanced rectal cancers in the elderly (UNICANCER PRODIGE 42/GERICO 12 study): Quality of life and comprehensive geriatric assessment
Eric François, Nicolas Magné, Rabia Boulahssass, et al.
Translational Oncology
|
November 18, 2021
Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program
Philippe A Cassier, Clémentine Peyramaure, Valery Attignon, et al.
Science Translational Medicine
|
January 24, 2024
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers
Aurélien Voissière, Carlos Gomez-Roca, Sylvie Chabaud, et al.
Breast (Edinburgh, Scotland)
|
October 8, 2021
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database
Mylène Annonay, Lisa Gauquelin, Romain Geiss, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2022
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade
Carlos Gomez-Roca, Philippe Cassier, Dmitriy Zamarin, et al.
Page
of 5